Двойное дно , отработает и будем расти .

21 Ara 2021

Почти отработало двойное дно . Ждем 24 цену.
с 5 января перенесли рассм лекарства на апрель
если будет ралли , то сценарий отработает

10 Şub 2022

Emir iptal

Двойное дно не сработало, и улетели вниз . Теперь не смотрим на ТА , ждем новостей про лектарство в апреле .

10 Şub 2022

Not

NEW HAVEN, Conn., Feb. 09, 2022 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that Vimal Mehta, Ph.D., Founder and Chief Executive Officer, will present at the upcoming SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16 at 2:20 p.m. ET. Dr. Mehta will highlight the Company’s neuroscience and immuno-oncology programs, artificial intelligence platform used to augment and accelerate the drug candidate discovery and development process, and its commercial and launch readiness plans for BXCL501.

1 Şub

İşlem elle kapatılmış